simransarin_ Profile Banner
Simran Sarin Profile
Simran Sarin

@simransarin_

Followers
119
Following
341
Media
32
Statuses
63

M3 @IowaMed | Cornea Research Fellow @uiowaeye ’24 | @UCBerkeley ’21 | writer @TheLens_oph | global health, health equity, big data // hiking, wine, travel

Berkeley, CA
Joined March 2021
Don't wanna be here? Send us removal request.
@simransarin_
Simran Sarin
7 months
It's an honor to have been selected! Huge thank you to my mentors Dr. Christopher Sales MD MPH and Dr. Mark Greiner MD and the Iowa Lions Eye Bank 👁️✨ @uiowaeye
@IowaMed
Carver College of Medicine
7 months
Meet Simran Sarin, one of our exceptional students chosen for the 2025 Dare to Discover campaign! 🧵 1/4
0
1
4
@TheLens_oph
The Lens: Ophthalmology Research Newsletter
7 days
This machine learning model predicted which patients with JIA are higher risk for uveitis using 4 variables: sex, age at onset, JIA subtype, and ANA status: 🔗 https://t.co/iouaU1RbDD #JIA #Ophthalmology #TheLens
Tweet card summary image
pubmed.ncbi.nlm.nih.gov
This study established a predictive model using routine clinical indicators to assess the risk of uveitis in JIA patients.
0
2
3
@simransarin_
Simran Sarin
2 months
Beyond grateful to have been awarded Best Paper of the Session at the #EBAA Cornea and Eye Banking Forum! #AAO #Orlando
0
0
2
@TheLens_oph
The Lens: Ophthalmology Research Newsletter
2 months
New research demonstrates the distribution of uveal melanoma by state in the US. Read more on the newest United States epidemiologic data here: 🔗 https://t.co/6xaL1kjrul #UvealMelanoma #Ophthalmology #Epidemiology #TheLens
Tweet card summary image
pubmed.ncbi.nlm.nih.gov
This nationwide study refines US UM incidence estimates and highlights persistent disparities by sex, race, age, and geography. The high prevalence of secondary malignancies underscores the need for...
0
1
0
@simransarin_
Simran Sarin
4 months
Highlights of #globalophthalmologysummit 2025: shared my work with Dr. Essuman, the first pediatric ophthalmologist trained in Ghana, reconnected with Dr. Ahmed and heard his amazing presentation, learned about structural competency from Dr. Mathe, new @YoungMDConnect friends!
0
0
1
@simransarin_
Simran Sarin
4 months
Curious about how bad nighttime driving is in patients with FECD? Read more about our study in collaboration with @UIowaDSRI here ⤵
@revoptom
Review of Optometry
6 months
Driving in the Dark: Fuchs’ Patients Have Reduced Nighttime Vision Despite Normal VA In a small pilot study, these individuals had to be nearly twice as close to roadside hazards to recognize them. https://t.co/H2kn4SRIpS #fuchsdystrophy #fuchs #optometry #cornea
0
0
1
@TheLens_oph
The Lens: Ophthalmology Research Newsletter
5 months
Aqueous IL-6 levels rise with diabetic retinopathy severity and correlate with DME. This largest prospective study to date suggests IL-6 may be a real-time biomarker and therapeutic target for diabetic retinopathy: 10.1016/j.oret.2025.06.014 #DiabeticRetinopathy #TheLens
0
1
4
@IowaMed
Carver College of Medicine
6 months
Congratulations to Dr. Adetayo Oladele-Ajose, a @uiowaeye resident, on being elected to the @IowaMedicalSoc Board of Directors. She joins physician leaders across the state in shaping health care policy and advocacy. https://t.co/wxS7oUkoNt
0
1
1
@TheLens_oph
The Lens: Ophthalmology Research Newsletter
6 months
Can UWFFA and OCT imaging assist in diagnosis and treatment of #pediatric anterior and intermediate uveitis? Read more here:
Tweet card summary image
pubmed.ncbi.nlm.nih.gov
Patients with PAIU present with inflammation involving both anterior segment, vitreous and peripheral retina and need systemic treatment. Monitoring of VC, macular edema, and PVL using multimodal...
0
2
0
@simransarin_
Simran Sarin
6 months
We quantified driving performance in FECD compared to controls with similar VA (~20/20) and contrast sensitivity. FECD pts had significantly worse driving performance and reacted to roadside hazards nearly 10x slower than someone at the legal BAC (0.08%)
Tweet card summary image
pubmed.ncbi.nlm.nih.gov
Despite normal VA and CS, patients with FECD performed significantly worse in driving simulations than controls. Driving disability was associated with tomographic measures of subclinical corneal...
0
0
0
@simransarin_
Simran Sarin
7 months
Confused about how RIME differs from MIRM, EM, SJS, and TEN? Check out our pediatric case of RIME on EyeRounds: https://t.co/qIPbwySFZ8
0
2
2
@simransarin_
Simran Sarin
7 months
Completely missed the blurb @uiowaIP shared about my cornea rotation in India! This was an amazing experience and I learned so much. Thanks to all my @uiowaeye mentors and the @IowaMed global health distinction track for continuing to support my global ophthal interests!! 🗺️
0
1
4
@TheLens_oph
The Lens: Ophthalmology Research Newsletter
7 months
Intravitreal anti-VEGF agents may promote healthy peripheral retinal growth in infants with type 1 #ROP. Read more here:
Tweet card summary image
pubmed.ncbi.nlm.nih.gov
This clinical evidence supports laboratory-based studies that regulation of VEGF using an intravitreal anti-VEGF agent increases developmental angiogenesis into the peripheral avascular retina while...
0
2
0
@simransarin_
Simran Sarin
7 months
GOS was one of my favorite conferences last year and I cannot wait to attend this year! I had the privilege of collaborating with cornea colleagues at Aravind Eye Hospital in Pondicherry after completing a rotation I designed there last winter. See you all in Chicago! 🌏👁️
0
0
3
@simransarin_
Simran Sarin
7 months
That’s a wrap on a great #ARVO2025 in SLC! A sunrise hike before our flight was the perfect end to a week of learning, collaborating, and great company🏔️
0
2
14
@simransarin_
Simran Sarin
7 months
Check out my poster (B0146) between 10:15-12:00 and 4:00-5:00 today! Our study validates GuttEye, automated software that quantifies guttae in specular microscopy imaging for FECD. Bonus: Dr. Hunt, PGY3 @uiowaeye, is a few boards away sharing his deep learning research! #ARVO2025
0
1
3
@simransarin_
Simran Sarin
7 months
This will be my first time at ARVO and I could not be more excited! Really proud of the work we will be sharing and its future applications 🔬 See you all in SLC! #ARVO2025 #fecd #ophthalmology
0
2
4
@simransarin_
Simran Sarin
8 months
that’s me! 🙋🏽‍♀️
0
1
6
@JAMAOphth
JAMA Ophthalmology
8 months
RCT: Suppressive valacyclovir treatment for herpes zoster ophthalmicus did not show a significant benefit at 12 months but demonstrated clinically relevant benefits at 18 months.
0
11
22
@simransarin_
Simran Sarin
8 months
Excited to be joining this amazing team!👩‍💻
@TheLens_oph
The Lens: Ophthalmology Research Newsletter
8 months
Welcoming our 2025-2026 Lens👁️ team! So excited for another year of newsletters, podcasts, AI, social media posts, and more!📷 For the latest in ophthalmology research: Subscribe 📩 https://t.co/5FUhywVOug Follow 📷X/IG @TheLens_oph Listen 🎧 https://t.co/lGSDdRd8K4
0
0
1